Company intelligence / Profile preview

Indiana Seed Fund II

Indianapolis, Indiana, United States

Ownership: Private
Development stage: Other

Overview

Indiana Seed Fund II is an $8.25 million early-stage venture capital fund managed by BioCrossroads, launched in April 2012 as a follow-on to Indiana Seed Fund I. It invests in life sciences startups focusing on biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech, and health information technology, with investments up to $1 million per company. Collectively with Seed Funds I-III, it has invested in 32 life sciences startups.

Industry: Investors

Beyond the preview

Go deeper on Indiana Seed Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indiana Seed Fund II.

Explore the full profile